These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1245091

  • 1. Disposition kinetics of quinidine.
    Ueda CT, Hirschfeld DS, Scheinman MM, Rowland M, Williamson BJ, Dzindzio BS.
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Disposition kinetics of two oral forms of quinidine.
    Mahon WA, Mayersohn M, Inaba T.
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Absolute quinidine bioavailability.
    Ueda CT, Williamson BJ, Dzindzio BS.
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [Abstract] [Full Text] [Related]

  • 9. Comparative disposition kinetics of two diastereomeric pairs of cinchona alkaloids in the dog.
    Abraham I, Ueda CT.
    J Pharm Sci; 1984 Apr; 73(4):452-6. PubMed ID: 6726627
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D, Nilsen OG, Storstein L, Amlie J, Jacobsen S.
    Eur J Clin Pharmacol; 1979 Apr 17; 15(3):187-92. PubMed ID: 456401
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of caffeine on the oral absorption and disposition of quinidine.
    Zeller FP, Ueda CT, Wulf BG, Meyers DG.
    Clin Pharm; 1984 Apr 17; 3(1):72-5. PubMed ID: 6697677
    [Abstract] [Full Text] [Related]

  • 14. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR, Vozeh S, Uematsu T, Guentert TW, Follath F.
    Clin Pharmacol Ther; 1987 Sep 17; 42(3):341-5. PubMed ID: 3621790
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K, Dahlqvist R.
    Br J Clin Pharmacol; 1981 Feb 17; 11(2):181-6. PubMed ID: 7213521
    [Abstract] [Full Text] [Related]

  • 19. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
    Vozeh S, Uematsu T, Guentert TW, Ha HR, Follath F.
    Clin Pharmacol Ther; 1985 May 17; 37(5):575-81. PubMed ID: 3987181
    [Abstract] [Full Text] [Related]

  • 20. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M, Salerno JA, Rondanelli R, Cristiani D, Chimienti M.
    Int J Clin Pharmacol Ther Toxicol; 1982 May 17; 20(5):212-8. PubMed ID: 7095920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.